Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
This is a chemiluminometric immunoassay. T3-uptake is measured using
an automated sandwich 2-site chemiluminometric immunoassay
on the Advia Centaur instrument. The specimen is incubated with
acridinium ester (AE)-labeled T3-BGG (bovine gamma globulin) and
unlabeled T3. The unlabeled T3 fills available thyroid-binding sites
in the specimen; and the AE-labeled T3-BGG does not bind to the binding
proteins in the specimen. The AE-labeled T3-BGG and the remaining
unlabeled T3 then compete for binding sites on a monoclonal mouse
anti-T3 antibody in the solid phase. A greater amount of unlabeled T3
bound to the binding proteins in the specimen results in more T3-BGG-AE
binding to the monoclonal antibody, an indication of a greater amount of
unsaturated binding proteins. A direct relationship exists between the
concentration of unsaturated binding proteins in a specimen and the relative
light units (RLU's) detected by the system. (Package insert: Bayer Advia:
Centaur TUP, 2004-03. Bayer Diagnostics, East Walpole, MA 02032)

